Zobrazeno 1 - 10
of 6 180
pro vyhledávání: '"MJ Martinez"'
Publikováno v:
BMC Musculoskeletal Disorders, Vol 23, Iss 1, Pp 1-11 (2022)
Abstract Background We assessed quality of life (QoL) of patients undergoing surgery for proximal femur fracture and performed a cost-effectiveness analysis of haemostatic drugs for reducing postoperative bleeding. Methods We analysed data from an op
Externí odkaz:
https://doaj.org/article/6cd6ca64fa16402aa7744c1a5a6d3816
Autor:
MJ Martinez Membrive, F Rueda Sobella, C Garcia Garcia, C Labata Salvador, T Oliveras Vila, S Montero Aradas, M Ferrer Massot, N El Ouaddi, J Serra Flores, J Lupon Roses, A Bayes Genis
Publikováno v:
European Heart Journal. Acute Cardiovascular Care. 11
Funding Acknowledgements Type of funding sources: Public hospital(s). Main funding source(s): Hospital Germans Trias i Pujol Background Cardiogenic shock (CS) is a severe complication of myocardial infarction (MI) and carries a high mortality. Clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8dbe809aa4e94aa74fb0d3d8ada340c3
https://doi.org/10.1093/ehjacc/zuac041.132
https://doi.org/10.1093/ehjacc/zuac041.132
Autor:
A Ganfornina Andrades, C Rodriguez Moreta, M Corrales Paz, MJ Martinez Bautista, MV Manzano Martin
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26aa53ee55a2e3312f1e355e084995aa
https://doi.org/10.1136/ejhpharm-2022-eahp.327
https://doi.org/10.1136/ejhpharm-2022-eahp.327
Publikováno v:
Section 5: Patient safety and quality assurance.
Background and importance Palbociclib and ribociclib are oral inhibitors of cyclin dependent kinases for firstline and secondline treatment of hormone receptor (HR) positive, HER2 negative locally advanced or metastatic breast cancer (BC). The most c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff2d3225c5ba14be1d9e44bfa8f47ba2
https://doi.org/10.1136/ejhpharm-2021-eahpconf.288
https://doi.org/10.1136/ejhpharm-2021-eahpconf.288
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Nivolumab and pembrolizumab are highly selective blockers of anti-programmed death-1 (PD-1). Nivolumab was authorised to be administered in weight based dosing (WBD) schedules at 3 mg/kg every 2 weeks (w) for all indications
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65377401be51716f5f703fc8eba7d9b1
https://doi.org/10.1136/ejhpharm-2020-eahpconf.188
https://doi.org/10.1136/ejhpharm-2020-eahpconf.188
Autor:
C Santos Rodriguez, I Moyano Prieto, G Blanco Sánchez, MJ Huertas Fernandez, MJ Martinez Bautista, M Domínguez López, A Salguero Olid, ME Rodriguez Mateos, F García Martín, MV Manzano Martin
Publikováno v:
Clinical pharmacy.
Background Until the arrival of new oral drugs to our hospital (dimethyl fumarate and teriflunomide), the drugs prescribed for the treatment of mild forms of relapsing remitting multiple sclerosis (RRMS) were for parenteral administration. Nowadays,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae51a7a8ed579c7aac14d4dc4004487f
https://doi.org/10.1136/ejhpharm-2017-000640.82
https://doi.org/10.1136/ejhpharm-2017-000640.82
Autor:
P. Ramirez Daffos, MJ Martinez Bautista, A Salguero Olid, M.J. Gómez Reina, M Domínguez López, A. Quilez Cutillas, I. Iglesias Lozano, G Blanco Sánchez
Publikováno v:
European Journal of Cancer. 72:S48-S49
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a9d5844e95be6049b1dd23c1ae0e8ef
https://doi.org/10.1016/s0959-8049(17)30239-3
https://doi.org/10.1016/s0959-8049(17)30239-3
Autor:
Rabie, Maha Abubakr Feissal1 (AUTHOR) maha.feissal@pua.edu.eg, El Benhawy, Sanaa A.2 (AUTHOR), Masoud, Inas M.3 (AUTHOR), Arab, Amal R. R.4 (AUTHOR), Saleh, Sally A. M.5 (AUTHOR)
Publikováno v:
Scientific Reports. 10/25/2024, Vol. 14 Issue 1, p1-9. 9p.
Autor:
Haglili, Ophir1 (AUTHOR), Sixsmith, Andrew2 (AUTHOR), Star, Ariel Pollock3 (AUTHOR), Shmueli, Moshe4 (AUTHOR), O'Rourke, Norm1,3,5 (AUTHOR) ORourke@bgu.ac.il
Publikováno v:
International Journal of Bipolar Disorders. 10/5/2024, Vol. 12 Issue 1, p1-11. 11p.